Phase I clinical and pharmacodynamic evaluation of oral CI-1033 in patients with refractory cancer. (Q53553054)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I clinical and pharmacodynamic evaluation of oral CI-1033 in patients with refractory cancer. |
scientific article |
Statements
Phase I clinical and pharmacodynamic evaluation of oral CI-1033 in patients with refractory cancer. (English)
Ralph G Zinner
John Nemunaitis
Irene Eiseman
Hyung Ju C Shin
Stephen C Olson
James Christensen
Xin Huang
Peter F Lenehan
Nicholas J Donato
Dong M Shin
1 May 2007
13
10
3006-3014